| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
July 07, 2005 |
|
|
| |
|
|
| |
|
|
|
Cambridge Healthtech Institute, Cambridge, Massachusetts
September 19-20, 2005
The progress in developing cancer vaccine therapies is picking up speed. Several hundred clinical trials exist and many of them are in Phase III. While the common goal for cancer immunotherapeutics is to boost the immune system and thereby fight cancer in various stages, the approaches to reach this goal vary widely and many obstacles and challenges still need to be overcome. Many questions need to be answered and discussed. What are the advantages of a whole cell vaccine? How can efficiency be increased while side effects are being reduced? Will new technologies in proteomics, comparative genomics or molecular immunology accelerate the development of effective therapeutic vaccines? Molecular markers – do they predict efficiency? In its second year, this conference brings together the scientific experts to “brainstorm” in panels, sessions and roundtable discussions case studies and new discoveries in Cancer Immunotherapies
|
|
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute |
|
|
Invited Speakers:
|
|
Go To http://www.healthtech.com/2005/cvc/index.asp for Full Information
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
|
|
|
|
|
|
|
|
Registration:
|
|
Go To http://www.healthtech.com/2005/cvc/index.asp for Full Information
|
|
|
E-mail:
|
|
chi@healthtech.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|